|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K(o)hne CH Lang I | 2011 | J Clin Oncol2011，29，： | 1 |
| 2 | Simulating nitrogen leaching and turnover in a subsurface-drained grassland receiving animal manure in Northern Germany using DRAINMOD-N II显示文摘 | Bechtold I Khne S Youssef M A | 2007 | Agric Water Manag2007，93，6： | 1 |
| 3 | Review of Coenosia attenuata Stein and its first record as a predator of important greenhouse pests in Turkey显示文摘 | Pohl D Kühne S Karaca I | 2012 | Phytoparasitica2012，40，： | 1 |
| 4 | Cetuximab plus irinotecan,flurouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | van Cutsem E Khne C H Láng I | 2011 | J Clin Oncol2011，29，15： | 1 |
| 5 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K(o)hne CH Láng I | 2011 | JClin Oncol2011，29，15： | 1 |
| 6 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K(o)hne CH Láng I | | 0，，15： | 1 |
| 7 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E Khne C H Láng I | 2011 | J Clin Oncol2011，29，15： | 1 |
| 8 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | VAN CUTSEM E K(O)HNE C H L(A)NG I | | 0，，15： | 1 |
| 9 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic color-ectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K(o)hne CH Láng I | | 0，，： | 1 |
| 10 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K(o)hne CH L(a)ng I | | 0，，15： | 1 |
| 11 | Cetuximab plus irinotecan,fluorouracil,and leucovorin as first-line treatment for metastatic colorectal cancer:updated analysis of overall survival according to tumor KRAS and BRAF mutation status显示文摘 | Van Cutsem E K?hne CH Láng I | | 0，，： | 1 |
| 12 | Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status 显示文摘 | Van Cutsem E K~hne CH LOng I | 2011 | J Clin Oncol2011，29，15： | 1 |
| 13 | Cetuximab plusirinotecan,fluorouracil, and leucovorin as first-line treat-ment for metastatic colorectal cancer: updated analysis ofoverall survival according to tumor KRAS and BRAFmutation status显示文摘 | van Cutsem E K?hne CH Ldng I | 2011 | J Clin Oncol2011，29，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员